Skip to content

Sharp offer well-established QP services, helping to streamline your product’s journey to trial and market in the EU and giving you and your customers confidence that your products have been manufactured to the very highest standards.

QP Release Services

Once a satisfactory audit is complete, your Sharp QP will issue a declaration that you can use to submit your Clinical Trial Authorisation (CTA). We can then work with you to manage the storage and distribution of your clinical trial supplies to your testing sites.

The Role of a (QP) Qualified Person

It is a requirement within the EU that all investigational and medicinal products manufactured or imported by organisations holding a MA IMP, have a QP to approve and release each batch of IMP for usage in clinical trials. QPs have gained personal knowledge of the quality systems used at the manufacturing site, usually through an EU Good Manufacturing Practice Audit.

QPs are assigned projects according to their specialist expertise and have personal and legal responsibility as defined by the EU Clinical Trial Directive (2001/20/EC).

Talk to our expert team today about your QP release needs.

Related Resources

At Sharp diversity, equality and inclusiveness are integral to who we are. We work with clients to improve the health of all lives, whatever colour - after all, a life without colour would be no life at all. We stand together with those in the fight for respect for all.

Connect with the Sharp team today at #OCTVirtual!

@ArenaIntOCT

Today, our US colleagues are recognizing all of those who made the ultimate sacrifice in the service of others. On their behalf, and that of everyone in Sharp, we’d like to say #thankyou. Wishing you and your families a safe and happy #MemorialDay.

#MemorialDay2020